15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Rayonier Inc, 1 rate it Buy or better, 4 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $22.00 to $28.00, so the covering firms are broadly aligned. The average target of $25.00 sits 13% above the current $22.09. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.16 next quarter toward $0.66 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Hold
Strong Buy120%
Buy00%
Hold480%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Rayonier Inc.
As of Jul, 1 of 5 firms rate RYN a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
RYN EPS & revenue forecast
EPS · NEXT QUARTER
$0.16
Range $0.13 – $0.21 · 5 analysts · -50% YoY
Next period, 5 analysts expect Rayonier Inc to earn $0.16 a share (range $0.13 – $0.21), versus $0.32 a year earlier. Full-year consensus is $0.47, growing to $0.66 the year after.
REVENUE · NEXT QUARTER
$404.5M
Range $331.4M – $442.4M · 5 analysts · +128% YoY
Revenue is expected to reach $404.5M (range $331.4M – $442.4M), +127.9% year-over-year. Full-year consensus is $1.5B, rising to $1.6B next year.
Top analysts covering Rayonier Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on RYN.
#1
AP
Anthony Pettinari
Citigroup · Rank #84
Hold
$22.00-0.4% to target
Overall win rate
45%
+ Follow
#2
Buck Horne
Raymond James · Rank #270
Buy
$28.00+26.7% to target
Overall win rate
37%
+ Follow
#3
MR
Michael Roxland
Truist Securities
Hold
$24.00+8.6% to target
Coverage
—
+ Follow
#4
MM
Matthew McKellar
RBC Capital
Hold
$26.00+17.7% to target
Coverage
—
+ Follow
#5
CM
Collin Mings
Raymond James
Buy
$28.00+26.7% to target
Coverage
—
+ Follow
RYN stock forecast FAQ
What is RYN's average 12-month price target?+
The 5 analysts with a live target average $25.00 for Rayonier Inc over the next 12 months, ranging from a $28.00 high to a $22.00 low.
Is RYN stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 5 analyst ratings, 1 are Buy or Strong Buy, 4 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for RYN?+
The Street-high target is $28.00 (Raymond James), and the Street-low is $22.00 (Citigroup). The average of all 5 active targets is $25.00.
How many Wall Street analysts cover RYN?+
5 analysts have an active rating on Rayonier Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering RYN?+
Among analysts who currently cover RYN, Anthony Pettinari of Citigroup has the strongest overall Quantellect track record (Rank #84). Their current call is Hold with a $22.00 target.
What is Rayonier Inc's projected EPS for next quarter?+
The consensus estimate is $0.16 per share (range $0.13 – $0.21) across 5 analysts. Full-year EPS is projected at $0.47, rising to $0.66 the following year.
How much revenue is Rayonier Inc expected to report next quarter?+
Consensus revenue is $404.5M (range $331.4M – $442.4M). Full-year revenue is projected at $1.5B, growing to $1.6B next year.
Have analysts been upgrading or downgrading RYN lately?+
As of Jul, 1 of 5 firms rate RYN a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their RYN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
